Back to News
Market Impact: 0.2
Biotech Options Buzz: UTHR, NMRA, EWTX
Source: schaeffersresearch.com
Futures & OptionsHealthcare & BiotechMarket Technicals & Flows
United Therapeutics, Neumora Therapeutics, and Edgewise Therapeutics appeared on the day’s unusual options-volume list, signaling elevated derivatives activity in biotech. The article provides no trade sizes, catalysts, price moves, or directional positioning, limiting conclusions about likely equity-market impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.05
Ticker Sentiment
EWTX0.10
NMRA0.10
UTHR0.10
More News
- Stocks face a key hurdle in next week’s U.S.-China summit. Here’s what’s at stake
- Three words from Kevin Warsh have Wall Street wondering how far the Fed will go with rate hikes
- Time for Cyclical Sector ETFs?
- Tokenization is set to change stock trading. These stocks could get a boost
- FTSE 100 today: Stocks drop as Hormuz tanker hit, Aramco cuts Europe supply
- Bank of Japan Hikes Interest Rates in a Split Vote; Yen Drops
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- AlphaSense Pricing: What Public Contract Data Shows in 2026
- Eli Lilly Q4 2025 Earnings: Revenue Surges 43% as Mounjaro and Zepbound Dominate the GLP-1 Market